<i>ATP13A2</i> variants in early‐onset Parkinson's disease patients and controls
Ana Djarmati(University of Lübeck), Christine Klein(University of Lübeck), Katja Lohmann(University of Lübeck), Heike Pawlack(University of Lübeck), Alfredo Ramı́rez(University of Cologne), Susen Winkler(University of Lübeck), Jens Volkmann(University of Würzburg), María Isabel Behrens(Universidad del Desarrollo), Anthony E. Lang(University of Toronto), Kathrin Reetz(Universitätsklinikum Aachen), Hartwig R. Siebner(University of Copenhagen), Vera Tadić(University of Lübeck), Thomas Gasser(Hertie Institute for Clinical Brain Research), Peter P. Pramstaller(Eurac Research), Vladimir Kostić(University of Belgrade), Norbert Brüggemann(University Hospital Schleswig-Holstein), Johann Hagenah(University of Lübeck), Ferdinand Binkofski(RWTH Aachen University), Daniela Berg(Christian-Albrechts-Universität zu Kiel)
Cited by 75
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Action observation activates premotor and parietal areas in a somatotopic manner: an fMRI study
|European Journal of Neuroscience|2001|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k